AIM ImmunoTech (AIM) Revenue (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Revenue came in at $22000.0 in Q1 2026, up 37.5% YoY from $16000.0 in Q1 2025, and up 4.76% on a QoQ basis from $21000.0 in Q4 2025.
AIM ImmunoTech (AIM) Revenue (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Revenue data on file, last reported at $22000.0 in Q1 2026.
- Quarterly Revenue rose 37.5% year-over-year to $22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94000.0 (down 35.62% YoY) and the FY2025 annual result came in at $88000.0, down 48.24% from the prior year.
- Revenue advanced to $22000.0 in Q1 2026, from $21000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $65000.0 in Q4 2023 to a low of $16000.0 in Q1 2025.
- A 5-year average of $36588.2 and a median of $35000.0 in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue surged 119.05% — and 2025, when it sank 60.0%.
- Tracing AIM's Revenue over 5 years: stood at $56000.0 in 2022, then increased by 16.07% to $65000.0 in 2023, then tumbled by 30.77% to $45000.0 in 2024, then sank by 53.33% to $21000.0 in 2025, then rose by 4.76% to $22000.0 in 2026.
- The last three Revenue figures came in at $22000.0 (Q1 2026), $21000.0 (Q4 2025), and $26000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | AIM ImmunoTech | 4.34 Mn | -5.62 Mn | 21,000.00 | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | 56,000.00 |
| Sep 30, 2022 | 21,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 33,000.00 |